Form D · Other Technology
Twine Health, Inc.
Cambridge, MA · CIK 0001705385
Offering snapshot reported May 4, 2017 · SEC filing
- Reported sold
- $750K Offering amount: $1.5M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Apr 19, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 4, 2017 | Initial | $749,996 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-286052
Source: Form D, filed May 4, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Scott Gilroy | Director |
| Mark Lester | Director |
| John Moore | Director, Executive |
| Franklin Moss | Director |
| Andrew Palmer | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
C/O Ngin Workplace 210 Broadway, Suite 201
Cambridge, MA, 02139
Cambridge, MA, 02139